Dr. Martin Alexander Gershon, MD, JD, MPH, is the CEO and Managing Partner of the Endeavor Group, which includes Endeavor Venture Capital, Endeavor Communications, and Endeavor Strategic Growth Advisors. Over the past 23 years, he has founded six startups and led Endeavor Venture Funds to over 100 investments and 24 exits, fostering a thriving ecosystem of partnerships and collaborations. He serves as Senior Executive Investor-in-Residence and Lead Mentor-in-Residence at Techstars, Advisor to the White House Moonshot CancerX Accelerator, and Senior Advisor to Fortune 500 healthcare, Big Tech, and finance companies. Dr. Gershon has also advised prominent Fortune 500 companies and global leaders, including GSK, Pfizer, Novartis, McKinsey, Goldman Sachs, and the Gates Foundation. Recognized as a “Top Voice” in Venture Capital by LinkedIn and honored by S&P as a Top 100 Healthcare Industry Leader, he has been featured on CNBC. Dr. Gershon hosts the Endeavor BetterHealth Webinar Series, serves as Editor-in-Chief for Partnering for BetterHealth Newsletter, and is a contributing writer to Fast Company. Dr. Gershon has a prominent academic, teaching, and mentoring career. He is a Harvard, McGill, and Columbia-trained neuroscientist, oncologist, former FDA attorney, and an award-winning Google Scholar in Entrepreneurship, as well as a Juilliard-trained musician.